FDA approval
Scope
Date
~
-
IPOs
Kosdaq cancels IPO approval for cloud developer InnoGrid
The Kosdaq market under the Korea Exchange said on Wednesday it has canceled its preliminary approval for InnoGrid Co.’s initial public offeri...
Jun 19, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean gets approval for LCO2 carrier from ABS
South Korea's Hanwha Ocean Co. said on Thursday it received Approval in Principle (AIP) from classification society ABS for a 40,000 cubic meter liq...
Jun 07, 2024 (Gmt+09:00)
-
Airlines
Korean Air expects US approval for Asiana merger by end-Oct: report
Korean Air Lines Co., South Korea’s No. 1 full-service carrier, expects to gain full approval from the US government by the end of October to ...
Jun 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Corporate restructuring
Hanwha Aerospace to spin off non-core units to focus on defense business
Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, is spinning off its non-core units to focus on defense and aerospace b...
Apr 03, 2024 (Gmt+09:00)
-
Entertainment
K Enter moves step closer to Nasdaq listing in May
K Enter Holdings Inc., an umbrella entity of South Korea-based entertainment companies creating original entertainment content and managing related ...
Mar 27, 2024 (Gmt+09:00)
-
Artificial intelligence
Lunit gets court approval for Volpara acquisition in New Zealand
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...
Mar 14, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Airlines
Japan approves Korean Air-Asiana merger
Japan has finally given the nod to the merger between South Korea’s No. 1 full-service carrier Korean Air Lines Co. and No. 2 Asiana Airlines ...
Jan 31, 2024 (Gmt+09:00)
-
Banking & Finance
S.Korea’s LS Group wins regulatory nod for securities biz
South Korea’s electrics components-to-energy conglomerate LS Group is set to start the securities business as it secured regulatory approval t...
Jan 18, 2024 (Gmt+09:00)
-
Corporate restructuring
Taeyoung becomes 1st Korean builder in debt workout in decade
The vast majority of creditors to Taeyoung Engineering & Construction Co. (Taeyoung E&C) have agreed to start debt restructuring for the tro...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets FDA approval for Alyglo
South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...
Dec 18, 2023 (Gmt+09:00)
-
Private equity
China's CICC enters S.Korea with its private equity fund
BEIJING – CICC Capital, a unit of China International Capital Corp. (CICC), has entered the South Korean market with the launch of a private e...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm gears up to boost epilepsy drug sales in Europe
SK Biopharmaceuticals Co. is gearing up to explore the European market for its flagship epilepsy drug Cenobamate, while looking for new mergers and ...
Nov 16, 2023 (Gmt+09:00)
-
Artificial intelligence
Lunit gets FDA approval for AI cancer diagnosis solution
South Korean medical AI company Lunit said on Tuesday its Lunit Insight DBT, an AI imaging diagnosis solution aiding in breast cancer diagnosis, has...
Nov 14, 2023 (Gmt+09:00)
-
Corporate restructuring
SK Energy to spin off tank terminal business as new logistics firm
SK Energy Co., a unit of South Korean oil refiner and battery maker SK Innovation Co., is spinning off its crude oil storage and shipment business t...
Nov 13, 2023 (Gmt+09:00)
-
Beauty & Cosmetics
Amorepacific's camellia-derived cosmetic ingredients get COSMOS
South Korean cosmetics giant Amorepacific Corp. said on Thursday its camellia-derived cosmetic ingredients got COSMetic Organic and natural Standard...
Nov 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Gencurix gets FDA OK for breast cancer prognosis analysis device
South Korean biotech company Gencurix Inc. announced on Wednesday its subsidiary GenoBio has received approval from the US Food and Drug Admini...
Nov 08, 2023 (Gmt+09:00)
-
Banking & Finance
Woori Bank to add two new branches in India 2024
South Korea's Woori Bank plans to open two new branches in India in the first half of next year. The bank announced on Tuesday it has obtained ...
Oct 31, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean to design digital vessels with ABS
South Korea’s Hanwha Ocean Co. on Sunday announced its conclusion of a basic accord with the Houston-based American Bureau of Shipping (ABS) t...
Oct 30, 2023 (Gmt+09:00)
-
Shipping & Shipbuilding
HD Hyundai develops electric propulsion system for large ships
HD Korea Shipbuilding & Offshore Engineering and HD Hyundai Heavy Industries Co. have secured Approval in Principle (AIP) from the UK's Lloyd's ...
Oct 27, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand